An Advisor to biotech companies in Europe, Dr. Derégnaucourt has more than 30 years of experience in the Health and Life Sciences sector having served in Senior Executive positions in the public and private sectors.
Dr. Derégnaucourt served as Vice-President for Research Applications and Industrial Partnerships at the Institut Pasteur, CEO of Medicen Paris Région the leading French biocluster, Vice-President of Global Project Management, Vice-Chairman of International Chemical and Pharmaceutical Development at Rhône Poulenc Rorer (now Sanofi), President of the Pierre Fabre Research Institute and subsequently Presidential Advisor at Laboratoires Fabre contributing to business development in China.
During his career in industry, Dr. Derégnaucourt made significant contributions to research and development with the international registration of several products including two blockbusters, Taxotère® and Clexane®/Lovenox®.
As a civil servant, Dr. Derégnaucourt served as Director of Biotechnologies for the French Ministry of Research. He contributed to the launch of EuroTransBio, an international funding initiative for small and medium sized enterprises collaborating in the area of modern biotechnology.
Dr. Derégnaucourt also served on the Board of Directors of leading research institutions such as Inserm, Inra, Affssaps and InCA. He was also a member of the French National Health Authority (HAS).
Dr. Derégnaucourt has a DVM and a Graduate degree in Pharmacology from the Paris Medical School. He is a Thesis Prize Winner and a Post-doctoral fellow at University of California at Los Angeles.